The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study
P. Scherer, Joachim Kügler(Technische Universität Dresden), Gerd Benesch, A. Plenio, H. Wilke-Burger, S. Zahrnt, I. Ringel, Friedel M. Reischies(Freie Universität Berlin), G. Finke, Iris‐Katharina Penner(University of Bern), Bettina Bergtholdt(Emovis), Susanne B. Breitkopf(Beth Israel Deaconess Medical Center), Kerstin Anvari, Kevin Hilbert(University of Erfurt), K. Isakowitsch, Peter Kaskel(Goethe University Frankfurt), I.M. Schulz(Emovis), Irmgard Nippert, Reinhard Ehret, E. Burger-Deinerth, Robert M. Hauser, A. Behringer, M. Zimmermann, H. Boldt, Alexander Rohr, Klaus Tiel‐Wilck, H Friedrich, Ines Peglau
Cited by 25
Related Papers
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries
|Translational Psychiatry|2020|702
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
|The Lancet Neurology|2015|523
Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: A systematic review
|Journal of Affective Disorders|2014|149
Personalization strategies in digital mental health interventions: a systematic review and conceptual framework for depressive symptoms
|Frontiers in Digital Health|2023|131